Document ID: chunk:federal_register_of_legislation:F2022C00900:front:0:p3
Version: federal_register_of_legislation:F2022C00900
Segment Type: other
Provision Reference: 
Character Range: 5917–8995

view that it is more probable than not that diabetes mellitus and death from diabetes mellitus can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.
     9             Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, diabetes mellitus or death from diabetes mellitus is connected with the circumstances of a person's relevant service:
(1)          having an endocrine disorder from the specified list of endocrine disorders before the clinical onset of diabetes mellitus;
            Note: specified list of endocrine disorders is defined in the Schedule 1 - Dictionary.
(2)          having a solid organ transplant or bone marrow transplant before the clinical onset of diabetes mellitus;
(3)          having glucocorticoid therapy as specified, before the clinical onset of diabetes mellitus, and where the glucocorticoid therapy as specified has ceased or decreased, the last dose of the therapy was received within the 30 days before the clinical onset of diabetes mellitus;
            Note: glucocorticoid therapy as specified is defined in the Schedule 1 - Dictionary.
(4)          being treated with a drug from the Specified List 1 of drugs, which cannot be ceased or substituted, for at least the seven days before the clinical onset of diabetes mellitus;
            Note: Specified List 1 of drugs is defined in the Schedule 1 - Dictionary.
(5)          being treated with a drug from the antidepressant or antipsychotic classes of drugs, which cannot be ceased or substituted, for at least the three months before the clinical onset of diabetes mellitus;
(6)          for type 1 diabetes mellitus only:
(a)          undergoing surgery to the pancreas before the clinical onset of diabetes mellitus;
(b)          having a specified pathological condition involving the pancreas before the clinical onset of diabetes mellitus;
                Note: specified pathological condition involving the pancreas is defined in the Schedule 1 - Dictionary.
(c)          having haemolytic uraemic syndrome before the clinical onset of diabetes mellitus;
             Note: haemolytic uraemic syndrome is defined in the Schedule 1 - Dictionary.
(d)          ingesting N-3-pyridyl methyl-N'-p-nitrophenyl urea (Vacor) within the 30 days before the clinical onset of diabetes mellitus; or
(e)          taking an immune checkpoint inhibitor or an interferon within the one year before the clinical onset of diabetes mellitus;

                Note: immune checkpoint inhibitor is defined in the Schedule 1 - Dictionary
(7)          for type 2 diabetes mellitus only:
(a)          having smoked at least five pack-years of tobacco products before the clinical onset of diabetes mellitus, and where smoking has permanently ceased, the clinical onset of diabetes mellitus has occurred within 15 years of cessation;
               Note: one pack-year